The Pharma AI Search Visibility Audit: how to track LLM presence (when rank trackers don’t)

If you publish medical/pharma content, you can’t manage what you don’t measure, and Search Console won’t hand you an “AI Overviews” tab. Google states AI features like AI Overviews and AI Mode are included in overall Search traffic reporting (Performance report, Web search type)¹.  

So you need an audit loop: build a pharma-safe query set, capture what AI answers say (and whether you’re cited), score visibility + risk, then fix pages in a way that strengthens E-E-A-T for a YMYL topic (health)².  

Why “LLM visibility” is different from classic SEO

Traditional SEO assumes the click is the goal. AI search breaks that assumption.

Google explicitly positions AI Overviews as a way to help users get the gist of complex questions quickly, and it may use “query fan-out” (multiple related searches across subtopics) before generating a response with supporting links¹.  

Translation: your content can influence the answer even when nobody clicks, and conversely, you can lose demand even if your rankings haven’t moved.

For pharma, there’s another twist: health is high-stakes. Low-quality or misleading medical content is treated differently, and quality standards are higher².  

That makes accuracy monitoring part of the visibility game, not a separate concern.

Regulatory and compliance guardrails (read this before you audit)

This article is about search visibility for non-promotional content (disease education, corporate science, patient resources) and does not advise promoting prescription medicines to the general public.

In most countries, advertising to the public for prescription-only medicines is prohibited³.  

France has specific provisions in the Code de la santé publique limiting public advertising and setting conditions for what can be advertised⁴.  

In the US, prescription drug promotion is regulated, with FDA oversight and requirements around truthful, balanced communication⁵.  

What this means in practice for your audit scope

• Include: disease education pages, diagnostic pathway explainers, safety/medical information at a general level, patient support service explanations (unbranded), corporate science pages, pipeline pages that are factual and non-promotional.
• Exclude from public query testing: anything that would effectively become Rx product promotion to the public (brand claims, superiority, calls to “ask your doctor for X,” etc.). You can keep safety questions about the product.
• Always run this in your internal process: “If an AI summary quoted this page out of context, would it accidentally read like a promotional claim?”

Keep your MLR/legal review workflows in the loop. Nothing below requires (or recommends) workarounds.

What you’re actually measuring

Think in three dimensions:

1) Presence

Does an AI answer appear for the query at all? If yes, are you referenced?

2) Attribution

Are you one of the linked sources/citations in the AI answer, or are competitors/guidelines getting all the credit?

3) Safety & fidelity

Does the AI answer:

• paraphrase you correctly,
• oversimplify,
• or drift into something risky (e.g., implying diagnosis, giving “normal ranges” without context)?

This matters because AI summaries in health have been criticized for missing clinical context, and Google has removed certain health AI Overviews after accuracy concerns were raised⁶.  

Even if you’re not responsible for the AI output, you don’t want your content to be the “good-looking quote” that supports a bad answer.

Step 1: Build a pharma-safe query set (the part most teams skip)

If you audit only head terms, you’ll learn nothing. AI Overviews tend to show on complex questions¹.  

A simple framework: 6 buckets that work across therapy areas

Create 15–30 queries per bucket (start small; you can expand later).

1. Definition & differentiation

• “What is [condition] vs [similar condition]?”
• “Difference between [biomarker] positive and negative”

2. Work-up & pathway (non-diagnostic language)

• “How is [condition] evaluated?”
• “What tests are used to assess [symptom] causes?”(Avoid “Do I have…” style in public content audits—keep it educational.)

3. Staging / severity / risk

• “What does stage [X] mean?”
• “What factors affect prognosis in [condition]?”(Use careful wording; avoid individualized predictions.)

4. Mechanism & science explainer (great for corporate blogs)

• “How does [pathway] contribute to [disease]?”
• “What is [target] in [disease area]?”

5. Living with / management (general)

• “How to talk to your doctor about [symptom]”
• “Questions to ask at diagnosis of [condition]”

6. Misconceptions & safety

• “Can [symptom] be caused by [benign cause]?”
• “When to seek medical help for [red flag symptom]”

Don’t mix audiences in the same audit

Split your query list into:

• Public / patient intent
• HCP / scientific intent (even if pages are public, the intent is different)

This will later help you interpret results and decide which pages deserve what type of author/reviewer signals.

Step 2: Capture AI answers in a way that’s repeatable (and policy-safe)

You don’t need fancy tooling at first. You need consistency.

Minimum viable capture (60–90 minutes)

For each query:

1. Open search in a clean session (logged out / incognito)
2. Record whether an AI Overview appears
3. If it appears:
   • copy the AI answer text into your log (short excerpt is enough),
   • list cited/source links shown,
   • note whether your domain appears,
   • screenshot for internal documentation.

Why the screenshot? Because AI outputs can change quickly and you want evidence when you decide to rewrite content or escalate a risk.

Note: if you use any third-party SERP (Search Engine Result Page) capture tooling, respect platform terms and local laws. The audit doesn’t require scraping.

Step 3: Use a logging sheet that forces clarity

Here’s a field list that actually gets used (copy into a spreadsheet):

Query details

• Query text
• Market / language
• Audience (Public vs HCP)
• Bucket (definition, pathway, etc.)

AI feature presence

• AI Overview present? (Y/N)
• Date captured
• Device (desktop/mobile)

Your visibility

• Your domain cited? (Y/N)
• If yes: which URL
• Citation position (top / mid / bottom)

Quality & risk notes

• Answer accurate? (Good / mixed / wrong)
• Missing context? (Y/N) — what’s missing
• Risk flags:
  • individualized advice
  • diagnostic language
  • dosing/treatment claims
  • brand mention / implied promotion
  • “normal range” with no context

Action

• Keep / improve / escalate
• Target page owner
• MLR needed? (Y/N)

Step 4: Score it (so you can prioritize like a grown-up)

You want a score that blends visibility with risk. Here’s a clean starting model:

Core metrics

• AIO Presence Rate = (# queries with AI Overview) / (total queries)
• Citation Share = (# AI Overviews citing your domain) / (# AI Overviews)
• Topical Coverage = (# buckets where you’re cited at least once) / (6 buckets)

Safety metric (pharma-specific)

• Risk Rate = (# AI Overviews where the answer creates a clinical/compliance risk) / (# AI Overviews)

A practical target: increase Citation Share without increasing Risk Rate.

That’s the whole game.

Step 5: Triangulate with Search Console (even though it’s blended)

Google’s guidance for site owners is straightforward: AI features are part of Search, and traffic from AI features is included in Search Console reporting (Performance report, Web search type)¹.  

In other words, yes, you can measure outcomes—but you’re reading blended signals.

What you can do with Search Console

• Track query/page trends before and after major content updates
• Watch CTR shifts on pages that are frequently cited in AI answers (from your audit log)
• Identify “high impressions, low clicks” pages that might be “answer-satisfying” (not a perfect proxy, but a useful hint)

What you shouldn’t pretend you can do

Don’t claim you have perfect AI Overview attribution in GSC as you can’t cleanly isolate AI Overviews performance as a separate segment in the standard interface¹.  

Use your audit log as the ground truth for “LLM presence,” and GSC as the outcome lens.

Step 6: Fix content in a way that helps AI without looking “SEO’d”

This is where people either win or write robotic fluff.

Google’s own guidance is: keep doing solid SEO fundamentals, meet technical requirements, and create helpful, reliable, people-first content. There’s no special markup you need to add just for AI Overviews¹.  

The pharma-friendly “Answer Block” (copy/paste template)

Put this near the top of the page (after a short intro):

• What it is (1–2 sentences)
• Why it happens / what drives it (2–3 bullets)
• How it’s typically evaluated (2–4 bullets)
• What varies by person (1–2 sentences: age, comorbidities, context)
• When to seek urgent care (red flags, bullets)
• Sources / last reviewed / reviewer

This structure is:

• easy for an LLM to extract,
• clinically safer (it includes context and red flags),
• not salesy.

Common fixes that move the needle

• Add explicit context where AI tends to hallucinate (“ranges vary by lab,” “interpretation depends on…”)
• Use guideline citations and date stamps (“Reviewed on…”)
• Strengthen internal linking between pathway pages (symptom → evaluation → next steps)
• Remove ambiguous phrasing that could read like a claim when quoted alone

If you need to reduce AI/snippet extraction (yes, sometimes you do)

Google notes you can control what appears in Search snippets using controls like nosnippet, max-snippet, or noindex—the same mechanisms apply in the AI features context.  o “earn” citations is to look like a responsible source. Ask your digital team to help you.

Minimal E-E-A-T checklist for pharma educational content

• Named author with relevant background (not “Editorial team”)
• Medical/legal review line when appropriate (with role, not just a name)
• Editorial policy page (how you source and update content)
• Last reviewed date + what changed
• Clear scope (“educational, not medical advice”)
• References that include guidelines and primary literature where possible

This doesn’t need to be heavy. It just needs to be real.

A cadence that works (without turning your team into SERP archaeologists)

• Monthly: run your 90–150 query set, update the log, refresh scoring
• Weekly: spot-check 10 high-risk queries (the ones where wrong answers could cause harm)
• Quarterly: update your “Answer Block” library and refresh the top 10 pages most frequently cited (or most frequently almost cited)

What not to do in pharma

• Don’t chase “LLM hacks.” Google explicitly says there are no extra requirements or special optimizations needed for AI Overviews beyond solid SEO fundamentals.  
• Don’t write content that reads like treatment recommendations for individuals.
• Don’t drift into product positioning in public-facing pages (and don’t let your internal linking accidentally create that implication when paragraphs get quoted out of context). EU and national rules prohibit Rx advertising to the public.  
• Don’t ignore when AI answers are unsafe. If AI search can amplify misinformation, monitoring is not optional in health.  

A quick starter pack

1. Pick one therapy area
2. Build 90 queries across the 6 buckets
3. Capture AI presence + citations + risk notes
4. Score: Presence Rate, Citation Share, Risk Rate
5. Fix the top 5 pages with:
   • Answer Block
   • stronger context + red flags
   • reviewer/last reviewed + references
6. Re-run in 30 days

That’s enough to produce a credible “before/after” story—and it keeps your compliance posture clean.

References:

1. AI features and your website, Google, Last accessed 17/01/2026
2. Search Quality Rater Guidelines: An Overview, Google, Last accessed 17/01/2026
3. DIRECTIVE 2001/83/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the Community code relating to medicinal products for human use, Last accessed 17/01/2026
4. Article L5122-6, Code de la Santa Publique, Last accessed 17/01/2026
5. The Office of Prescription Drug Promotion (OPDP), FDA, Last accessed 17/01/2026
6. ‘Dangerous and alarming’: Google removes some of its AI summaries after users’ health put at risk, The Guardian, Last accessed 17/01/2026

Olivier Gryson, PharmD, MSc
25 years of experience in digital marketing in the pharmaceutical industry
Special focus on AI Search in Pharma Marketing